Improving Global Outcomes (KDIGO) group has updated chronic kidney disease treatment guidelines to help slow disease progression in adults. A JAMA article published Wednesday summarized the revised ...

A recent study led by Paul DeCaen, Ph.D., associate professor of Pharmacology, has identified novel molecular mechanisms by ...

When was the last time you had your blood sugar and blood pressure checked? If you’re a smoker, a drinker, are overweight, ...

New research identifies diabetes as an independent predictor of major adverse cardiovascular events in patients with both ...

Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population, ...

Healthinote is a smartphone-based toolkit designed to boost patient engagement by providing personalised, trustworthy, and ...

The environment strongly influences health outcomes, especially in industrialized societies. A new study from the Columbia ...

Those bubbles in your toilet bowl might be more than a quirky bathroom observation. Persistent foamy urine often signals ...

The goal with ProKidney Corp.'s rilparencel-branded therapy is "to demonstrate the therapy's potential to preserve kidney ...

North East and North Cumbria NHS has begun a year-long rollout of the Healthinote digital health platform to support patients ...

Shares of ProKidney rose in early trading after it received FDA support for its path to accelerated approval of its rilparencel kidney disease drug. The stock was up 5.4% to $3.89 Tuesday and has more ...

A small study shows sensors embedded in a face mask appear to detect compounds linked to kidney disease. This is part of ...